{"id":145509,"title":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T22:29:26.446000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html?wbdisable=true","snippet":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr /…","rawSnapshotUrl":"/api/snapshots/raw/145509","browseUrl":"https://replay.healtharchive.ca/job-1/20250418222926/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html?wbdisable=true#ha_snapshot=145509","mimeType":"text/html","statusCode":200}